Keyora Skin Systems Nutrition - Elastin Peptide EP-3: The Elastin-Derived Peptide Bioavailability and Signaling Matrix: From Gastrointestinal Processing to Human Exposure and Dermal Signaling
Background Oral elastin hydrolysates are preparation-specific peptide mixtures, not intact elastic fibers or a single defined peptide. Their skin relevance therefore requires a molecularly traceable sequence from source and hydrolysis through gastrointestinal processing, human plasma exposure, fibroblast response, and tissue-level outcomes. Objective This five-chapter synthesis develops the Keyora Oral Elastin Peptide Exposure-to-Fibroblast Bridge and integrates it with the Keyora Human Elastin Peptide Exposure Matrix, Keyora Dermal Fibroblast Response Matrix, and Keyora Elastokine Molecular Context Matrix. It examines sequence-dependent digestion and transport; human pharmacokinetics; cellular biosynthesis; endogenous elastokine receptor signaling; and photoaging-associated elastin turnover. Mechanistic Synthesis Chapter 1 follows pre-hydrolyzed peptides through gastric pepsin, pancreatic proteases, brush-border peptidases, and PEPT1 (SLC15A1)-mediated uptake. Pro-Gly and Gly-Pro illustrate sequence-dependent differences in hydrolysis and intact transport. Chapter 2 evaluates human plasma as an exposure compartment. Shigemura et al. (2012) identified circulating Pro-Gly after skipjack-tuna bulbus arteriosus hydrolysate ingestion (10 g/60 kg), with a Cmax of approximately 18 μM at 30 minutes; about 20% of peak remained at 240 minutes. Iwasaki et al. (2024) identified four linear and four cyclic dipeptides, reporting Pro-Gly Cmax of 14.63 μM. Chapter 3 examines human dermal fibroblast models: 0.1–10 μg/mL Pro-Gly over 72 hours increased extracellular tropoelastin, while Shiratsuchi et al. (2016) reported elastin synthesis and proliferation responses to fish elastin hydrolysate and Pro-Gly, with maximal proliferation at 25 ng/mL. Chapter 4 distinguishes dietary Pro-Gly from endogenous GXXPG-related elastokines and describes EBP–PPCA–Neu-1 recognition, GM3-to-LacCer signaling, parallel PKA/B-Raf and PI3K/p110γ/Raf-1 inputs, MEK/ERK activation, AP-1, and pro-MMP-1 expression. κ-Elastin at 50 μg/mL produced an approximately six-fold pro-MMP-1 increase in the cited fibroblast model. Chapter 5 connects tropoelastin production with fibrillin/fibulin-associated deposition and LOX-mediated cross-linking, while examining UV-responsive MMP-12-mediated elastin degradation. Human-skin evidence included approximately 11.9-fold MMP-12 mRNA induction at 16 hours after UV exposure and 41 elastin-derived peptides mapped across 36 MMP-12 cleavage sites. Conclusion One fish elastin hydrolysate ingestion study reported 4% elasticity improvement versus 2% with placebo, alongside wrinkle-related and blood-flow outcomes. These findings complement, but do not collapse into, the separate pharmacokinetic and cell-culture evidence. Plasma concentration, cultured-cell biosynthesis, and human skin mechanical change are related research layers, but they remain distinct measurement endpoints. The Keyora framework therefore prioritizes preparation identity, sequence verification, exposure concentration and timing, assay-specific fibroblast endpoints, and human skin measurements as distinct, connected evidence layers. The synthesis supports a research pathway for oral elastin-peptide evaluation without treating cellular findings or one preparation-specific clinical observation as proof of efficacy for every source or finished formulation.
Authors
- Xu Jin (ORCID: https://orcid.org/0009-0007-5798-1996)
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-14
- DOI
- https://doi.org/10.5281/zenodo.24221143
- Primary Topic
- Protein Hydrolysis and Bioactive Peptides
- Type
- article
- Field-Weighted Citation Impact
- 0.00